Clinical prognostic factors in pleural mesothelioma: best supportive care and anti-tumor treatments in a real-life setting

February 4, 2021 | Comments Off on Clinical prognostic factors in pleural mesothelioma: best supportive care and anti-tumor treatments in a real-life setting

Acta Oncologica 2021 January 27 [Link] Thomas Ringgaard Petersen, Vasiliki Panou, Christos Meristoudis, Ulla Møller Weinreich, Oluf Dimitri Røe Abstract Background: This study aims to investigate patient- and disease characteristics…

Recurrence of mesothelioma after a macroscopic complete resection procedure: is a second radical surgery justified?

February 3, 2021 | Comments Off on Recurrence of mesothelioma after a macroscopic complete resection procedure: is a second radical surgery justified?

Interactive Cardiovascular and Thoracic Surgery 2021 January 26 [Link] Hany Hasan Elsayed, Aly Sherif Hassaballa, Taha Aly Ahmed, Hazem Youssef Sharkawy Abstract A best evidence topic was written according to…

Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma

February 2, 2021 | Comments Off on Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma

Cancer Cytopathology 2021 January 25 [Link] Mohammed S I Mansour, Tomas Seidal, Ulrich Mager, Katalin Dobra, Hans Brunnström, Annika Dejmek Abstract Background: Malignant mesothelioma (MM) is a therapy-resistant tumor, often…

Fluorescence in situ hybridization detection of chromosome 22 monosomy in pleural effusion cytology for the diagnosis of mesothelioma

February 1, 2021 | Comments Off on Fluorescence in situ hybridization detection of chromosome 22 monosomy in pleural effusion cytology for the diagnosis of mesothelioma

Cancer Cytopathology 2021 January 25 [Link] Yoshiaki Kinoshita, Makoto Hamasaki, Shinji Matsumoto, Masayo Yoshimura, Ayuko Sato, Tohru Tsujimura, Toshiaki Kamei, Kunimitsu Kawahara, Akinori Iwasaki, Kazuki Nabeshima Abstract Background: Malignant pleural…

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

January 29, 2021 | Comments Off on First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

Lancet 2021 January 21 [Link] Paul Baas, Arnaud Scherpereel, Anna K Nowak, Nobukazu Fujimoto, Solange Peters, Anne S Tsao, Aaron S Mansfield, Sanjay Popat, Thierry Jahan, Scott Antonia, Youssef Oulkhouir,…

Establishment and histopathological study of patient-derived xenograft models and primary cell lines of epithelioid malignant peritoneal mesothelioma

January 28, 2021 | Comments Off on Establishment and histopathological study of patient-derived xenograft models and primary cell lines of epithelioid malignant peritoneal mesothelioma

Experimental Animals 2021 January 21 [Link] Zhi-Ran Yang, Zhi-Gao Chen, Zhong-He Ji, Yu-Lin Lin, Jue Zhang, Ru Ma, Zhao Li, Xi Jiang, Qian Chen, Xue-Mei DU, Yan Li Abstract Malignant…

The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3

January 27, 2021 | Comments Off on The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3

Cancers 2021 January 14 [Link] Elly Marcq, Jonas R M Van Audenaerde, Jorrit De Waele, Céline Merlin, Patrick Pauwels, Jan P van Meerbeeck, Scott A Fisher, Evelien L J Smits…

Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival

January 26, 2021 | Comments Off on Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival

Lung Cancer 2020 December 31 [Link] Puey Ling Chia, Sagun Parakh, Prudence Russell, Hui K Gan, Khashayer Asadi, Val Gebski, Carmel Murone, Marzena Walkiewicz, Zhanqi Liu, Bibhusal Thapa, Fiona E…

Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial

January 25, 2021 | Comments Off on Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial

The Lancet Oncology 2021 January 12 [Link] B C John Cho, Laura Donahoe, Penelope A Bradbury, Natasha Leighl, Shaf Keshavjee, Andrew Hope, Prodipto Pal, Michael Cabanero, Kasia Czarnecka, Karen McRae,…

Living with mesothelioma: A qualitative study of the experiences of male military veterans in the UK

January 22, 2021 | Comments Off on Living with mesothelioma: A qualitative study of the experiences of male military veterans in the UK

European Journal of Oncology Nursing 2020 December 19 [Link] Stephanie Ejegi-Memeh, Liz Darlison, Anne Moylan, Angela Tod, Virginia Sherborne, Clare Warnock, Bethany Hope Taylor Abstract Purpose: The UK has the…

Categories